Wound care companies develop products and technologies that support the treatment, protection and healing of acute and chronic wounds. Their work spans infection control, tissue repair, wound monitoring and the management of complex conditions such as diabetic ulcers and pressure injuries.
This category includes companies working on:
Browse 22 UK wound care companies below.
Bio-inspired adhesion peptides for medical and industrial use
Zentraxa is a biomaterials company engineering bio-inspired adhesion peptides using a proprietary synthetic peptide manufacturing platform. Inspired by marine mollusc chemistry, the platform designs and produces novel peptides with exceptional adhesion properties in wet and submerged environments. Medical applications…
Enzymatic wound debridement therapy derived from maggot biology
SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical maggots that degrades non-viable wound tissue including fibrin, elastin, and collagen to prepare the wound bed for healing. The product is in…
Preclinical mRNA nanoparticle therapeutics for chronic inflammatory disease
EVolution Therapeutics is a preclinical-stage biotechnology company developing mRNA nanoparticle and hydrogel-based therapeutics to resolve chronic inflammation and support tissue repair. Spun out of Aston University, its platform delivers mRNA encoding pro-resolving proteins directly to sites of disease. The lead…
Tension-preserved human skin models for dermatology and drug testing
Ten Bio is a contract research organisation providing physiologically tensioned human skin models for pharmaceutical, dermatology and cosmetic research. Its patented TenSkin platform maintains full-thickness, ethically sourced surgical skin with its barrier, appendages and minor cell populations, preserving functional…
Bacteriophage-integrated antibacterial textiles for surgical implant infection prevention
Oxford Silk Phage Technologies is a biotechnology company developing antibacterial biomaterials that integrate bacteriophages into silk-based medical textiles, for use in surgical implants and wound care devices. The technology embeds high-density cocktails of bacteriophages throughout the textile structure, producing…
Medical-grade collagen biomaterials for regenerative medicine devices
Evergen develops, manufactures, and supplies medical-grade collagen biomaterials and engineered tissue scaffolds for use in medical devices and regenerative medicine. Operating from Glasgow under GMP conditions, the company partners with OEM medical device manufacturers to develop and supply collagen formulations…
Novel antibiotic-sparing therapeutics for chronic wound care
ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented controlled-release drug delivery technology designed to manage wound exudate and reduce reliance on antibiotics, addressing antimicrobial resistance in…
Autologous platelet-based biotherapies for chronic wound healing
Biotherapy Services is a clinical-stage company developing autologous biotherapies for wound healing and tissue regeneration. Its lead treatment is a gel prepared at the point of care from a concentrate of the patient's own platelets, activated with the patient's own thrombin to release growth factors and other…
Contract development and manufacture of nanofibrous biomaterials for medical devices
The Electrospinning Company designs, develops, and manufactures nanofibrous biomaterials for implantable medical devices and regenerative medicine applications. Using electrospinning technology, the company produces four proprietary membrane platforms: resorbable Mimetix, permanent Kalyptix, biosynthetic Symatix, and…
Electrospun biomimetic scaffold platform for wound repair
Corryn Biotechnologies is a Welsh biotechnology company developing an electrospinning platform that fabricates nano- and microfibrous polymer scaffolds directly onto wound sites at the point of care. The resorbable scaffolds mimic the architecture of the extracellular matrix, supporting tissue regeneration in chronic…
Plant-based molecular farming platform for bio-identical collagen production
LeafyColl is a biotech developing a molecular farming platform for the scalable, plant-based production of bio-identical human collagen and other specialty proteins. The system uses engineered plants as programmable bio-factories to produce high-purity collagen for applications spanning regenerative medicine, wound…
Asymmetric biomaterial skin substitutes for acute and chronic wounds
Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material architectures, in which opposing faces of the scaffold present distinct physicochemical properties to simultaneously support wound bed healing…
Global medical technology company specialising in chronic condition management
Convatec is a global medical products and technologies company focused on chronic condition management. The group develops and manufactures advanced wound care dressings, ostomy care, continence care and infusion care products, including hydrofiber-based, antimicrobial and tissue-derived biomaterial wound dressings…
Reprogrammed stem cell therapies for vascular disease and chronic wounds
ReproGo is a Belfast-based regenerative medicine company developing Advanced Therapy Medicinal Products through direct cell reprogramming of adult cells into vascular lineages. The company's manufacturing approach produces stem cell-derived vascular cells and organoids through a xeno-free, low-dose process designed…
Small-molecule drugs targeting cellular ageing and senescence
Five Alarm Bio Limited is a biotechnology company discovering small-molecule therapies for diseases associated with ageing. Its research targets chemical damage that accumulates inside cells, aiming to reinforce protective mechanisms and delay cellular senescence rather than destroy senescent cells. Candidate…
Amniotic membrane biotherapies for ocular surface repair and regeneration
NuVision Biotherapies is a regenerative medicine company developing tissue-based biotherapies for ocular surface disease and trauma. Its proprietary processing technology manufactures dry-preserved human amniotic membrane grafts that retain the membrane's natural barrier and healing properties whilst enabling ambient…
Lab-grown human skin equivalent for cosmetic and pharmaceutical testing
Labskin is a contract research organisation offering preclinical testing services built around a proprietary full-thickness, lab-grown human skin equivalent. The model incorporates primary human keratinocytes and fibroblasts and is uniquely capable of hosting the skin's natural microflora, enabling microbiome-relevant…
Probiotic microbiome platform for skin health and dermatological conditions
SkinBioTherapeutics is a biotechnology company developing microbiome-based technologies for skin health. Its proprietary platform harnesses lysates derived from probiotic bacteria to improve skin barrier function, reduce infection risk, and support wound healing. Programmes target cosmetic skincare, psoriasis, eczema,…
Microbiology and biofilm testing contract research organisation
5D Health Protection Group is a UK-based contract research and microbiology testing organisation providing antimicrobial, biofilm and infection control research services to healthcare, medical device and industrial clients. The company offers accredited laboratory testing, product evaluation and outsourced R&D support…
Cell therapy for vascular regeneration in ischaemic and wound healing conditions
VascVersa is a Belfast-based regenerative medicine company developing cell therapies for vascular regeneration and repair. The company's technology uses vasoreparative cells to stimulate new blood vessel formation and restore blood supply in conditions characterised by impaired circulation. The lead programme targets…